Real-life management of dual antiplatelet therapy interruption: the REGINA survey.

Background: Concern about procedure-related bleeding is a major reason for premature discontinuation of dual oral antiplatelet therapy (APT); treatment cessation is detrimental in patients with coronary artery disease (CAD), especially after drug-eluting stent (DES) placement. The nationwide REGINA survey was designed to evaluate how the interruption of dual APT is managed in the 'real world'.

Methods: Physicians (2700/4581) were randomly selected to participate in a computer-assisted telephone interview.